Heartflow (NASDAQ:HTFL) CEO Sells $2,168,286.00 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John Farquhar sold 38,900 shares of Heartflow stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $55.74, for a total value of $2,168,286.00. Following the completion of the transaction, the chief executive officer owned 251,983 shares in the company, valued at approximately $14,045,532.42. This represents a 13.37% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

John C.M. Farquhar also recently made the following trade(s):

• On Monday, October 12th, John Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $49.57, for a total value of $1,928,273.00.
• On Friday, September 11th, John Farquhar sold 3,890 shares of Heartflow stock. The shares were sold at an average price of $50.00, for a total value of $194,500.00.
• On Thursday, September 10th, John Farquhar sold 35,010 shares of Heartflow stock. The shares were sold at an average price of $46.42, for a total value of $1,625,164.20.
• On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00.
• On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total transaction of $1,470,420.00.
• On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The stock was sold at an average price of $39.06, for a total transaction of $607,773.60.

Heartflow Trading Down 1.5%

NASDAQ:HTFL traded down $0.86 during midday trading on Tuesday, reaching $55.80. 1,276,518 shares of the stock traded hands, compared to its average volume of 1,611,085. The company has a fifty day moving average of $51.56 and a 200 day moving average of $34.87. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $60.56.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. The business had revenue of $64.08 million for the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. Heartflow’s revenue was up 47.7% on a year-over-year basis. On average, research analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current year.

Hedge Funds Weigh In On Heartflow

Several hedge funds and other institutional investors have recently modified their holdings of HTFL. Teachers Retirement System of The State of Kentucky purchased a new stake in Heartflow in the third quarter worth about $1,684,000. Allworth Financial LP boosted its position in Heartflow by 116.4% during the 3rd quarter. Allworth Financial LP now owns 1,145 shares of the company’s stock valued at $57,000 after acquiring an additional 616 shares in the last quarter. Pier 88 Investment Partners LLC bought a new position in shares of Heartflow in the 3rd quarter worth approximately $174,000. M&G PLC purchased a new position in shares of Heartflow in the 3rd quarter valued at approximately $15,978,000. Finally, Pictet Asset Management Holding SA purchased a new position in shares of Heartflow in the 3rd quarter valued at approximately $551,000.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Benchmark reaffirmed a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. UBS Group initiated coverage on Heartflow in a research report on Wednesday, September 9th. They issued a “neutral” rating and a $55.00 price objective on the stock. Wall Street Zen cut Heartflow from a “buy” rating to a “hold” rating in a research note on Saturday. Canaccord Genuity Group upped their target price on Heartflow from $45.00 to $56.00 and gave the company a “buy” rating in a report on Tuesday, September 22nd. Finally, JPMorgan Chase & Co. raised their price target on Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $48.62.

About Heartflow

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.